lobbying_activities: 2101604

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2101604	bbc93648-c4b8-4d91-896d-3c6dcb937ff8	Q1	HOLLAND & KNIGHT LLP	18466	THE BIOSIMILARS FORUM	2018	first_quarter	MMM	Medicare reimbursement issues, FDA regulation of biosimilars; H.R. 1625, Consolidated Appropriations Act of 2018.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE	120000		0	0	2018-04-02T14:15:27.313000-04:00